daratumumab
SpainDrugs containing this active substance
-
It is used in adults to treat multiple myeloma (a cancer of the bone marrow), quiescent multiple myeloma, and AL amyloidosis (a blood and bone marrow disorder where abnormal proteins build up in the organs).
Form: solution for injection
Active substance Dosage daratumumab 1800 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults aged 18 years or older to treat multiple myeloma, which is a type of bone marrow cancer.
Form: solution for infusion, concentrate
Active substance Dosage daratumumab 100 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults aged 18 years or older to treat multiple myeloma, which is a type of bone marrow cancer.
Form: solution for infusion, concentrate
Active substance Dosage daratumumab 400 mg Manufacturer: Janssen-Cilag International N.V